Author | Year* | Design | Patients | No | In favor of | Main results |
---|---|---|---|---|---|---|
Wohrle et al [34] | 2003 | retrospective | STEMI/NSTEACS | 403 | IC | reduced incidence of MACE at 30 days |
Bellandi et al [27] | 2004 | prospective, randomized | STEMI | 45 | IC | higher salvage index and LV functional recovery (serial gated SPECT) |
Romagnoli et al [32] | 2005 | prospective, matched | STEMI/NSTEACS | 74 | IC | increased coronary flow (cTFC) |
Galache et al [29] | 2006 | prospective, randomized | STEMI/NSTEACS | 137 | neutral | no difference in the incidence of MACE at 1 year |
Thiele et al [33] | 2008 | prospective, randomized | STEMI | 154 | IC | reduced infarct size and extent of MO (MRI at 2 days) |
Dominguez-Rodriguez et al [28] | 2009 | prospective, randomized | STEMI | 50 | IC | larger reduction in soluble CD40 ligand |